Pulmatrix Inc (PULM) is not a strong buy for a beginner, long-term investor at this time. The company faces significant financial challenges, with declining revenue, negative earnings, and a shrinking cash position. Additionally, there are no clear positive technical signals or trading trends to support an immediate investment. Given the lack of strong catalysts and poor financial performance, it is advisable to hold off on investing in this stock.

Technical Analysis

The MACD histogram is positive at 0.0861, indicating mild bullish momentum, but it is contracting. RSI is neutral at 52.844, suggesting no overbought or oversold conditions. Moving averages are converging, indicating a lack of a clear trend. Support and resistance levels are at S1: 2.462, Pivot: 2.858, and R1: 3.253, showing the stock is trading near its pivot point.

Positive Catalysts

The company expects its current cash position to fund operations into Q1 2027, providing some short-term operational stability.

Neutral/Negative Catalysts

The company reported a Q4 GAAP EPS of -$1.41, significant financial challenges, and a cash position decline from $9.5 million to $4.1 million. Revenue dropped to 0 in Q3 2025, and gross margin also fell to 0%. These factors may negatively impact investor confidence and stock performance.

Financial Performance

In Q3 2025, revenue dropped to 0 (-100% YoY), net income dropped to -$877,000 (-66.1% YoY), EPS dropped to -0.24 (-66.2% YoY), and gross margin dropped to 0 (-100% YoY). The company is facing severe financial challenges.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No data available for analyst ratings or price target changes.

Analyst Rating

Wall Street analysts forecast PULM stock price to rise

Buy

Hold

Sell

Current: 2.990

Low

Averages

High